Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ananth

Showing results (341-350 of 344) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 344 results.
NEJM Evidence|February 6, 2024
Circulating Angiogenic Factor Levels in Hypertensive Disorders of PregnancyRavi Thadhani, Elizabeth Lemoine, Sarosh Rana, et al.
American Journal of Obstetrics and Gynecology|November 13, 2025
Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancyAnders H Berg, Vinicius F Calsavara, Martin Hund, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Science Translational Medicine|April 17, 2024
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and humanJason D Roh, Claire Castro, Andy Yu, et al.
Pageof 35

Showing results (341-350 of 344) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 344 results.
NEJM Evidence|February 6, 2024
Circulating Angiogenic Factor Levels in Hypertensive Disorders of PregnancyRavi Thadhani, Elizabeth Lemoine, Sarosh Rana, et al.
American Journal of Obstetrics and Gynecology|November 13, 2025
Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancyAnders H Berg, Vinicius F Calsavara, Martin Hund, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Science Translational Medicine|April 17, 2024
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and humanJason D Roh, Claire Castro, Andy Yu, et al.
Pageof 35